iSpecimen Inc. Operating Income
iSpecimen Inc. (ISPC) reported Operating Income of -$1.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-14
- iSpecimen Inc. operating income (loss) for the quarter ending 2026-06-30 was -$1.36M.
- iSpecimen Inc. operating income (loss) for the quarter ending 2026-03-31 was -$2.54M.
- iSpecimen Inc. operating income (loss) for the quarter ending 2025-12-31 was -$2.69M.
- iSpecimen Inc. operating income (loss) for the quarter ending 2025-09-30 was -$2.83M.
- iSpecimen Inc. operating income (loss) for fiscal 2025 was -$8.98M.
- iSpecimen Inc. operating income (loss) for fiscal 2024 was -$12.73M.
- iSpecimen Inc. operating income (loss) for fiscal 2023 was -$11.17M.
- iSpecimen Inc. operating income (loss) for fiscal 2022 was -$10.19M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.36M 10-Q · filed 2026-08-14 | -$3.90M 10-Q · filed 2026-08-14 | -$6.59M derived: sum of 3 quarters · filed 2026-08-14 | -$9.42M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$2.54M 10-Q · filed 2026-05-18 | -$5.23M derived: sum of 2 quarters · filed 2026-05-18 | -$8.06M derived: sum of 3 quarters · filed 2026-05-18 | -$9.88M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$5.52M derived: sum of 2 quarters · filed 2026-04-01 | -$7.34M derived: sum of 3 quarters · filed 2026-08-14 | -$8.98M 10-K · filed 2026-04-01 |
| 2025-09-30 | -$2.83M 10-Q · filed 2025-11-17 | -$4.65M derived: sum of 2 quarters · filed 2026-08-14 | -$6.29M 10-Q · filed 2025-11-17 | -$12.13M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$1.82M 10-Q · filed 2026-08-14 | -$3.46M 10-Q · filed 2026-08-14 | -$9.30M derived: sum of 3 quarters · filed 2026-08-14 | -$11.01M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$1.64M 10-Q · filed 2026-05-18 | -$7.48M derived: sum of 2 quarters · filed 2026-05-18 | -$9.18M derived: sum of 3 quarters · filed 2026-05-18 | -$11.37M derived: sum of 4 quarters · filed 2026-05-18 |
| 2024-12-31 | -$5.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | -$7.55M derived: sum of 2 quarters · filed 2026-04-01 | -$9.73M derived: sum of 3 quarters · filed 2026-04-01 | -$12.73M 10-K · filed 2026-04-01 |
| 2024-09-30 | -$1.71M 10-Q · filed 2025-11-17 | -$3.89M derived: sum of 2 quarters · filed 2025-11-17 | -$6.89M 10-Q · filed 2025-11-17 | -$9.76M derived: sum of 4 quarters · filed 2025-11-17 |
| 2024-06-30 | -$2.18M 10-Q · filed 2025-08-14 | -$5.18M 10-Q · filed 2025-08-14 | -$8.05M derived: sum of 3 quarters · filed 2025-08-14 | -$10.25M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$3.00M 10-Q · filed 2025-05-19 | -$5.87M derived: sum of 2 quarters · filed 2025-05-19 | -$8.07M derived: sum of 3 quarters · filed 2025-05-19 | -$11.63M derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | -$2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-14 | -$5.07M derived: sum of 2 quarters · filed 2025-04-14 | -$8.63M derived: sum of 3 quarters · filed 2025-04-14 | -$11.17M 10-K · filed 2025-04-14 |
| 2023-09-30 | -$2.19M 10-Q · filed 2024-11-07 | -$5.76M derived: sum of 2 quarters · filed 2024-11-07 | -$8.30M 10-Q · filed 2024-11-07 | -$10.44M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$3.56M 10-Q · filed 2024-08-06 | -$6.10M 10-Q · filed 2024-08-06 | -$8.25M derived: sum of 3 quarters · filed 2024-08-06 | -$11.35M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$2.54M 10-Q · filed 2024-05-07 | -$4.68M derived: sum of 2 quarters · filed 2024-05-07 | -$7.79M derived: sum of 3 quarters · filed 2024-05-07 | -$10.37M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$5.24M derived: sum of 2 quarters · filed 2024-03-13 | -$7.83M derived: sum of 3 quarters · filed 2024-03-13 | -$10.19M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$3.10M 10-Q · filed 2023-11-02 | -$5.69M derived: sum of 2 quarters · filed 2023-11-02 | -$8.04M 10-Q · filed 2023-11-02 | -$10.04M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | -$2.59M 10-Q · filed 2023-08-02 | -$4.94M 10-Q · filed 2023-08-02 | -$6.94M derived: sum of 3 quarters · filed 2023-08-02 | -$8.40M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | -$2.36M 10-Q · filed 2023-05-04 | -$4.35M derived: sum of 2 quarters · filed 2023-05-04 | -$5.81M derived: sum of 3 quarters · filed 2023-05-04 | -$7.34M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | -$1.99M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-30 | -$3.45M derived: sum of 2 quarters · filed 2023-03-30 | -$4.98M derived: sum of 3 quarters · filed 2023-03-30 | -$5.93M 10-K/A · filed 2023-03-30 |
| 2021-09-30 | -$1.46M 10-Q · filed 2022-11-08 | -$2.99M derived: sum of 2 quarters · filed 2022-11-08 | -$3.93M 10-Q · filed 2022-11-08 | -$4.86M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | -$1.53M 10-Q · filed 2022-08-04 | -$2.47M 10-Q · filed 2022-08-04 | -$3.41M derived: sum of 3 quarters · filed 2022-08-04 | -$4.13M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$942.64K 10-Q · filed 2022-05-10 | -$1.88M derived: sum of 2 quarters · filed 2022-05-10 | -$2.60M derived: sum of 3 quarters · filed 2022-05-10 | -$2.91M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | -$934.45K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$1.66M derived: sum of 2 quarters · filed 2022-03-22 | -$1.96M derived: sum of 3 quarters · filed 2022-03-22 | -$2.41M 10-K · filed 2022-03-22 |
| 2020-09-30 | -$723.08K 10-Q · filed 2021-11-04 | -$1.03M derived: sum of 2 quarters · filed 2021-11-04 | -$1.47M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$305.01K 10-Q · filed 2021-08-10 | -$748.99K 10-Q · filed 2021-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |